
薬剤耐性が、血液がん治療のサイレントリスクでなくなる日
がん治療は今、新たなイノベーションの時代を迎えています。免疫療法、分子標的治療、細胞療法の進歩により、患者の治療アウトカムは劇的に改善しつつあります。ただし、これらの画期的な治療法のすべては、抗微生物薬という脆弱な基盤の上に成り立っています。
Founded in 1826, University College London (UCL) is a leading public research university located in the heart of London. Established with a pioneering commitment to open access and equality in education, UCL is recognised worldwide for excellence in research, innovation and teaching across medicine, engineering, social sciences, law and the humanities. Home to a diverse and inclusive academic community, it combines rigorous scholarship with a strong social mission. Through interdisciplinary collaboration and global partnerships, UCL advances knowledge and solutions that improve lives and shape a more sustainable, equitable world.











